Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koen van Besien

Showing results (141-150 of 241) with videos related to

Pageof 25
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 8, 2013
A phase I study of CPX-351 in combination with busulfan and fludarabine conditioning and allogeneic stem cell transplantation in adult patients with refractory acute leukemiaUsama Gergis, Gail Roboz, Tsiporah Shore, et al.
Leukemia & Lymphoma|December 15, 2010
T-cell-depleted allogeneic transplant without donor leukocyte infusions results in excellent long-term survival in patients with multiply relapsed Lymphoma. Predictors for survival after transplant relapseVaishalee P Kenkre, Sarah Horowitz, Andrew S Artz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 31, 2011
Progressive improvement in cutaneous and extracutaneous chronic graft-versus-host disease after a 24-week course of extracorporeal photopheresis--results of a crossover randomized studyHildegard T Greinix, Koen van Besien, Ahmet H Elmaagacli, et al.
The Journal of Biological Chemistry|January 5, 2008
Osteopontin regulates actin cytoskeleton and contributes to cell proliferation in primary erythroblastsJeong-Ah Kang, Ying Zhou, Tahlia L Weis, et al.
Blood|December 22, 2012
Identifying familial myelodysplastic/acute leukemia predisposition syndromes through hematopoietic stem cell transplantation donors with thrombocytopeniaJane E Churpek, Eric Nickels, Rafael Marquez, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 15, 2011
Phase I-II study of clofarabine-melphalan-alemtuzumab conditioning for allogeneic hematopoietic cell transplantationKoen van Besien, Wendy Stock, Elizabeth Rich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2003
Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow TransplantationPhilip J Bierman, John W Sweetenham, Fausto R Loberiza, et al.
Blood|March 6, 2002
Allogeneic blood cell transplantation following reduced-intensity conditioning is effective therapy for older patients with myelofibrosis with myeloid metaplasiaSteven M Devine, Ron Hoffman, Amit Verma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2010
Temsirolimus has activity in non-mantle cell non-Hodgkin's lymphoma subtypes: The University of Chicago phase II consortiumSonali M Smith, Koen van Besien, Theodore Karrison, et al.
Experimental Hematology & Oncology|January 10, 2019
Outcomes following second allogeneic stem cell transplant for disease relapse after T cell depleted transplant correlate with remission status and remission duration after the first transplantYun Fan, Andrew S Artz, Koen van Besien, et al.
Pageof 25

Showing results (141-150 of 241) with videos related to

Sort By:
Pageof 25
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 8, 2013
A phase I study of CPX-351 in combination with busulfan and fludarabine conditioning and allogeneic stem cell transplantation in adult patients with refractory acute leukemiaUsama Gergis, Gail Roboz, Tsiporah Shore, et al.
Leukemia & Lymphoma|December 15, 2010
T-cell-depleted allogeneic transplant without donor leukocyte infusions results in excellent long-term survival in patients with multiply relapsed Lymphoma. Predictors for survival after transplant relapseVaishalee P Kenkre, Sarah Horowitz, Andrew S Artz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 31, 2011
Progressive improvement in cutaneous and extracutaneous chronic graft-versus-host disease after a 24-week course of extracorporeal photopheresis--results of a crossover randomized studyHildegard T Greinix, Koen van Besien, Ahmet H Elmaagacli, et al.
The Journal of Biological Chemistry|January 5, 2008
Osteopontin regulates actin cytoskeleton and contributes to cell proliferation in primary erythroblastsJeong-Ah Kang, Ying Zhou, Tahlia L Weis, et al.
Blood|December 22, 2012
Identifying familial myelodysplastic/acute leukemia predisposition syndromes through hematopoietic stem cell transplantation donors with thrombocytopeniaJane E Churpek, Eric Nickels, Rafael Marquez, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 15, 2011
Phase I-II study of clofarabine-melphalan-alemtuzumab conditioning for allogeneic hematopoietic cell transplantationKoen van Besien, Wendy Stock, Elizabeth Rich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2003
Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow TransplantationPhilip J Bierman, John W Sweetenham, Fausto R Loberiza, et al.
Blood|March 6, 2002
Allogeneic blood cell transplantation following reduced-intensity conditioning is effective therapy for older patients with myelofibrosis with myeloid metaplasiaSteven M Devine, Ron Hoffman, Amit Verma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2010
Temsirolimus has activity in non-mantle cell non-Hodgkin's lymphoma subtypes: The University of Chicago phase II consortiumSonali M Smith, Koen van Besien, Theodore Karrison, et al.
Experimental Hematology & Oncology|January 10, 2019
Outcomes following second allogeneic stem cell transplant for disease relapse after T cell depleted transplant correlate with remission status and remission duration after the first transplantYun Fan, Andrew S Artz, Koen van Besien, et al.
Pageof 25